ALUVI Financial Statements From 2010 to 2024

ALUVI Stock  EUR 2.79  0.00  0.00%   
UV Germi financial statements provide useful quarterly and yearly information to potential UV Germi SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on UV Germi financial statements helps investors assess UV Germi's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting UV Germi's valuation are summarized below:
UV Germi SA does not at this time have any fundamental measures for analysis.
Check UV Germi financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UV Germi's main balance sheet or income statement drivers, such as , as well as many indicators such as . ALUVI financial statements analysis is a perfect complement when working with UV Germi Valuation or Volatility modules.
  
This module can also supplement various UV Germi Technical models . Check out the analysis of UV Germi Correlation against competitors.

UV Germi SA Company Current Valuation Analysis

UV Germi's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current UV Germi Current Valuation

    
  7.06 M  
Most of UV Germi's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UV Germi SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, UV Germi SA has a Current Valuation of 7.06 M. This is 99.9% lower than that of the Machinery sector and 98.15% lower than that of the Industrials industry. The current valuation for all France stocks is 99.96% higher than that of the company.

UV Germi SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining UV Germi's current stock value. Our valuation model uses many indicators to compare UV Germi value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UV Germi competition to find correlations between indicators driving UV Germi's intrinsic value. More Info.
UV Germi SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UV Germi's earnings, one of the primary drivers of an investment's value.

About UV Germi Financial Statements

UV Germi shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although UV Germi investors may analyze each financial statement separately, they are all interrelated. The changes in UV Germi's assets and liabilities, for example, are also reflected in the revenues and expenses on on UV Germi's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
UV GERMI, Socit anonyme develops and manufactures UV sterilizers for water treatment applications. The company offers its products for applications in the areas of drinking water, waste water, water in public swimming pools, rain water, air, and surfaces, as well as industrial water in food processing, pharmaceutical, and cosmetic industries. UV GERMI operates under Pollution Treatment Controls classification in France and is traded on Paris Stock Exchange. It employs 30 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for ALUVI Stock Analysis

When running UV Germi's price analysis, check to measure UV Germi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UV Germi is operating at the current time. Most of UV Germi's value examination focuses on studying past and present price action to predict the probability of UV Germi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UV Germi's price. Additionally, you may evaluate how the addition of UV Germi to your portfolios can decrease your overall portfolio volatility.